-

DecisionRx and Beanstalk Benefits Join Forces to Offer Medication Therapy Optimization to Benefit Platform Members

Leveraging clinical pharmacists, pharmacogenomics, and advanced data science, Medication Therapy Optimization aims to improve patient outcomes and end trial-and-error prescribing

INDIANAPOLIS--(BUSINESS WIRE)--DecisionRx, Inc., a value-based healthcare company reducing the cost of care by helping individuals eliminate medication failure, today announced a partnership with Philadelphia-based Beanstalk Benefits. Beanstalk Benefits is now offering the DecisionRx Medication Therapy Optimization (MTO) program to their benefit platform members to improve patient outcomes and help care teams optimize prescribing decisions for each patient.

“We each know what works for us and what doesn’t across our daily lives – our learning styles, motivators, even hair products. When it comes to medicines, though, individuals haven’t historically had access to the science behind why a treatment may succeed or not,” said Beanstalk Benefits CEO Matthew Sydney. “DecisionRx is an exceptional complement to Beanstalk health resources like Tiny Health’s gut tests and Vous Vitamin’s personalized vitamins. Better health outcomes require better engagement of individuals at a personal level, and we’re excited to collaborate with DecisionRx to empower people to take more informed action.”

Research indicates that around 40% of prescriptions are either ineffective or cause new medical issues, leading to ER visits, hospitalizations, and even deaths that are preventable with optimized medication therapy. Utilizing its data-driven MTO platform, DecisionRx's clinically trained pharmacists provide healthcare providers with detailed information and tailored recommendations, enabling more effective customization of medication plans for individual patients.

“When it comes to improving health outcomes and costs, we’re all more likely to use what we choose for ourselves,” said DecisionRx co-founder and President Travis Morgan. “Employee uptake of employer-sponsored benefits is sometimes low, yet consumers spend $480 billion annually on wellness. The demand is there. What’s been missing is the mechanism to put the benefits decisions in employees’ hands.”

Currently, Beanstalk Benefits offers 40+ services and products for members to choose from, allowing employers of any size, as well as freelance or independent contractors, to access the same benefit resource options. The company's target buyers include individuals and employers with under 5,000 employees.

About Beanstalk Benefits

Beanstalk Benefits is a new way for employers and other sponsors to offer benefits: Let employees choose their own. We give each unique individual broader access to the increasingly specific health, wealth and wellbeing resources now available, so they can choose what they need. By offering employees this flexibility, benefits sponsors are better able to meet the dynamic needs of each member of the diverse and modern workforce – while consolidating vendor management, benefits cost and complexity under a single contract and aggregated reporting.

About DecisionRx

DecisionRx is a technology-enabled healthcare services company, improving patient outcomes and reducing healthcare costs by helping physicians optimize prescribing decisions for their patients. DecisionRx clinical pharmacists work on patients’ behalf to mitigate medication failure by making personalized medication recommendations to prescribers, informed by the latest clinical and data-science, and delivered in a value-based care model. Medication failure accounts for at least 16% of total healthcare spending, and medication therapy optimization has been shown to reduce total annualized cost of care by $3,600 for Medicare patients and $1,200 for patients under age 65.

Contacts

Media Contacts
Beanstalk Benefits
Media@BeanstalkBenefits.com

Alexis Feinberg
ICR Healthcare on behalf of DecisionRx
646-277-1252
Alexis.Feinberg@ICRHealthcare.com

DecisionRx, Inc.


Release Versions

Contacts

Media Contacts
Beanstalk Benefits
Media@BeanstalkBenefits.com

Alexis Feinberg
ICR Healthcare on behalf of DecisionRx
646-277-1252
Alexis.Feinberg@ICRHealthcare.com

More News From DecisionRx, Inc.

DecisionRx Appoints Health Insurance Executive Michael Tilton as Chief Growth Officer

INDIANAPOLIS--(BUSINESS WIRE)--DecisionRx, Inc., a value-based healthcare company reducing the cost of care by helping individuals eliminate medication failure, today announced that seasoned healthcare executive Michael Tilton has been appointed as Chief Growth Officer. In this role, Tilton will lead the company’s activities to expand commercialization of the DecisionRx Medication Therapy Optimization (MTO) platform. “DecisionRx has been implemented by payers and accountable care organizations...

DecisionRx Partners with MotivHealth to Deliver Medication Therapy Optimization to Health Plan Members

INDIANAPOLIS--(BUSINESS WIRE)--DecisionRx, Inc., a value-based healthcare company helping physicians eliminate medication failure, today announced a partnership with Utah-based MotivHealth. MotivHealth is now offering the DecisionRx Medication Therapy Optimization (MTO) program to select members to improve patient outcomes and reduce healthcare costs by helping physicians optimize prescribing decisions for each patient. “MotivHealth was founded to break the mold in the insurance market, and Dec...

DecisionRx and AmeriLife Come Together to Enhance Medication Efficacy Among Medicare Patients

INDIANAPOLIS--(BUSINESS WIRE)--DecisionRx, Inc., a value-based healthcare company reducing the cost of care by helping individuals eliminate medication failure, announced today a collaboration with AmeriLife Group, LLC (“AmeriLife”), a leading provider of insurance and retirement solutions, to provide Medicare Advantage and Medicare Supplement patients access to its Medication Therapy Optimization (MTO) platform. The DecisionRx MTO platform provides patients and providers with an analysis of wh...
Back to Newsroom